NCT06367751 2026-03-11
LIQPLAT
University Hospital, Basel, Switzerland
Phase NA Active not recruiting
Clinical Trials
48 trialsNCT07396090 2026-02-09
Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
NCT05478486 2026-02-04
Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours
Godavari Biorefineries Limited
Phase 1 Completed
NCT07098299 2025-11-06
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Barbara Ann Karmanos Cancer Institute
Phase 1 Recruiting
NCT06130254 2025-10-14
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06543056 2025-07-30
A Study of ES014 in Subjects With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05978102 2025-07-23
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2 Recruiting
NCT06970132 2025-05-14
Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2 Not yet recruiting
NCT06497010 2025-05-01
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
The Affiliated Hospital Of Guizhou Medical University
Phase EARLY_PHASE1 Recruiting
NCT05038150 2025-04-30
Study of SGN1 in Patients With Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2 Recruiting
NCT05103345 2025-04-30
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2 Recruiting
NCT04751786 2025-04-04
PRECIOUS-01
Radboud University Medical Center
Phase 1 Active not recruiting
NCT05916248 2025-04-01
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT05599048 2025-03-24
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
University of California, San Francisco
Phase 1/2 Recruiting
NCT06173219 2025-02-27
Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.
China-Japan Friendship Hospital
Phase 1/2 Recruiting
NCT05701150 2025-02-17
CONNECT
AIO-Studien-gGmbH
Recruiting
NCT06404905 2024-12-27
BT02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT06408688 2024-12-27
ISCA-CHECK
University Hospital, Basel, Switzerland
Phase 4 Recruiting
NCT06139211 2024-12-20
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Recruiting
NCT06084286 2024-11-19
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors
Sichuan University
Phase 1 Recruiting
NCT05076591 2024-10-30
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Suspended
NCT06404281 2024-08-22
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Changzhou No.2 People's Hospital
Phase 1 Recruiting
NCT06081907 2024-05-30
Promise
Hunan Province Tumor Hospital
Phase 1/2 Recruiting
NCT03874897 2024-04-30
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Peking University
Phase 1 Completed
NCT05291182 2024-02-02
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT06037317 2024-02-02
A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Recruiting
NCT06211647 2024-01-18
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
Chinese PLA General Hospital
Phase 1 Recruiting
NCT06197139 2024-01-09
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT06170294 2023-12-14
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
Peking University
Phase 1 Recruiting
NCT06072989 2023-10-10
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors
Shanghai East Hospital
Phase 1 Recruiting
NCT06006793 2023-09-01
A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT05933668 2023-07-06
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
Peking University
Phase 1 Not yet recruiting
NCT05498519 2023-05-11
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT05837299 2023-05-01
A Study of IMC008 for Advanced Solid Tumors
Changhai Hospital
Phase 1 Recruiting
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT05805956 2023-04-10
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT05644509 2022-12-09
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Unknown
NCT05205408 2022-11-29
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Bengbu Medical University
Phase 1 Unknown
NCT05539768 2022-09-14
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor
The Affiliated Hospital of Qingdao University
Phase EARLY_PHASE1 Not yet recruiting
NCT05515185 2022-08-25
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors
The First People's Hospital of Lianyungang
Phase EARLY_PHASE1 Unknown
NCT03163732 2022-05-09
PROFILER 02
Centre Leon Berard
Phase NA Completed
NCT05228119 2022-05-09
A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Unknown
NCT05202561 2022-03-23
A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Bengbu Medical University
Phase 1 Unknown
NCT05122572 2022-01-20
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Wuxi People's Hospital
Phase 1 Unknown
NCT05020119 2021-08-25
Neoantigen-expanded Autologous Immune Cell Therapy
Chang Gung Memorial Hospital
Phase 1 Unknown
NCT02979392 2019-09-25
Phase I Study of TENPA in Advanced Solid Cancer
Seoul National University Hospital
Phase 1 Terminated
NCT03929965 2019-04-29
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Shanghai Changzheng Hospital
Phase NA Unknown
NCT00509613 2009-09-18
Phase 1 Study With Sorafenib and Sirolimus
Radboud University Medical Center
Phase 1 Completed